Salt Lake City, Utah, United States
I hold a Master of Science in Immunology of Infectious Diseases from the London School of Hygiene and Tropical Medicine and a Bachelor of Science in Pharmaceutical Sciences from the University of Georgia College of Pharmacy. I have extensive experience in anti-malarial approaches and Plasmodium structural biology. I am currently pursuing my PhD in microbiology and immunology.
• Investigating asymptomatic Plasmodium infections. • Constructing P. berghei parasites with exogenous protein expression. • Investigating CD8 Tcell Plasmodium epitopes.
• Determined the minimum inoculum of resistance (MIR) for early-stage antimalarial compounds in collaboration with the WHO’s Medicines for Malaria Venture (MMV) and the Gates Foundation Malaria Drug Accelerator (MalDA). • Investigated cross resistance potential of early-stage antimalarial compounds against P. falciparum mutant parasites.
• Successfully created cKO models in P. falcpiarum using a combination of diCre conditional deletion and CRISPR/Cas9 to assess parasite survival after protein ablation. • Effectively tagged protein orthologs in P. knowlesi with fluorescence or epitope tags.
• Tripp Lab: Investigated the role of G protein on pAKT in RSV. Practiced BSL2 aseptic techniques for continuous culture of 293T human embryonic kidney cells.
Investigated formulations of Atropine for ocular delivery with reduced toxicities. Identified and isolated complexations in Homatropine HBr formulations. Investigated Tetracaine HCl stability. Practiced GMPs. Relevant Equipment: UV-Vis, HPLC